Creating a comprehensive dataset to understand type 2 diabetes and its pathways to health
Bridge2AI: Salutogenesis Data Generation Project
This study is gathering information from over 4,000 people with type 2 diabetes to better understand the condition and find ways to improve health and treatment options for everyone living with it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11197893 on NIH RePORTER |
What this research studies
This research focuses on generating a large, ethically-sourced dataset to enhance our understanding of type 2 diabetes mellitus (T2DM) and its pathways to health. By collecting data from over 4,000 participants across the United States, the project aims to analyze complex, multimodal data that reflects various stages of diabetes. The methodology includes both cross-sectional and longitudinal data collection, allowing researchers to predict disease trajectories and identify factors that contribute to recovery. This innovative approach will enable future artificial intelligence and machine learning research to provide critical insights into diabetes management and treatment.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with type 2 diabetes, particularly those at various stages of the disease.
Not a fit: Patients with type 1 diabetes or those without a diabetes diagnosis may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing and potentially reversing type 2 diabetes, benefiting patients significantly.
How similar studies have performed: Previous research has shown promise in using large datasets and AI approaches to improve understanding and treatment of diabetes, indicating that this project builds on established methodologies.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Lee, Aaron — University of Washington
- Study coordinator: Lee, Aaron
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.